| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 01/21/2004 | EP0937048B1 HETEROCYCLE DERIVATIVES WHICH INHIBIT FACTOR Xa |
| 01/21/2004 | CN1469878A Aza-and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
| 01/21/2004 | CN1469862A 2,2-diphenyl butanamide derivatives and medicines containing the same |
| 01/21/2004 | CN1468852A Iridium catalyzed enantiotropic hydrosubstituting process of aromatic pyridine ring and pyrazine ring |
| 01/20/2004 | US6680321 4-((1-piperazinylmethyl)-benzamide derivatives; hypotensive agents; immunomodulators |
| 01/20/2004 | US6680312 Sulfonamide derivatives, their production and use |
| 01/17/2004 | CA2435399A1 New anthracene derivatives and their use as pharmaceutical preparations |
| 01/15/2004 | WO2004006355A2 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | WO2004006354A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | WO2004006352A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | WO2004005406A2 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/15/2004 | WO2004005288A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | WO2004005260A1 A-`7-halo-2-quino (xa-) linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents |
| 01/15/2004 | WO2004004720A1 3-`(hetero) arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 01/15/2004 | WO2004004651A2 Therapeutic amides |
| 01/15/2004 | US20040010037 Cyanophenyl derivative |
| 01/15/2004 | US20040009987 4-phenylpiperidinyl- or 4-phenylpiperazinyl-; including N-oxides |
| 01/15/2004 | US20040009985 Bicyclo 4.4.0 antiviral derivatives |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/15/2004 | CA2492692A1 Charge transport compositions which are quinazoline derivatives and electronic devices made with such compositions |
| 01/15/2004 | CA2492690A1 Polymeric charge transport compositions and electronic devices made with such compositions |
| 01/15/2004 | CA2492689A1 Electronic devices made with electron transport and/or anti-quenching layers |
| 01/15/2004 | CA2492688A1 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 01/15/2004 | CA2492686A1 Charge transport compositions on the basis of triarylmethanes and their use in electronic devices |
| 01/14/2004 | EP1380306A1 Remedies for psychoneurosis |
| 01/14/2004 | EP1379510A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | EP1379251A1 Inhibitors of akt activity |
| 01/14/2004 | EP1379250A2 A method of treating cancer |
| 01/13/2004 | US6677376 Complexes comprising rotamase inhibitors and cyclophilins, administered for prevention of neurodegenarative diseases such as parkinson's or alzheimer's disease |
| 01/13/2004 | US6677336 Substituted piperazine compounds |
| 01/13/2004 | US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus |
| 01/13/2004 | US6676926 Radiopharmaceuticals for diagnosing Alzheimer's disease |
| 01/13/2004 | CA2053359C Heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
| 01/08/2004 | WO2004003599A2 Anisotropic films based on 1,8-naphthoylene-1',2'-benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making |
| 01/08/2004 | WO2004002983A2 Therapeutic piperazine derivatives useful for treating pain |
| 01/08/2004 | WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 01/08/2004 | WO2004002944A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002940A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2004002925A2 Process for preparing (r)-aryloxypropionic acid ester derivatives |
| 01/08/2004 | WO2003086279A3 Inhibitors of akt activity |
| 01/08/2004 | WO2003084928A8 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers |
| 01/08/2004 | WO2003077828A3 Novel florfenicol-type antibiotics |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006230 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 01/08/2004 | US20040006142 Ocular tension depressor |
| 01/08/2004 | US20040006104 For therapy and prophylaxis of diseases and conditions associated with undesirable or abnormal inflammatory responses, such as ischemia-reperfusion injury, asthma, arthritis |
| 01/08/2004 | US20040005607 Bis-diazo,triaryl and aryldiazo-N-arylphenazonium quencher moieties, substituted with electron withdrawing, electron donating substituents which induce polarity in delocalized aryl/diazo ring system; use as labels attached to biomolecules |
| 01/08/2004 | CA2491156A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | CA2490950A1 Inhibitors of hcv ns5b polymerase |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378509A1 Drugs containing triazaspiro 5.5]undecane derivatives as the active ingredient |
| 01/07/2004 | EP1377640A2 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds |
| 01/07/2004 | EP1377560A1 Piperazine derivatives as tachykinin antagonists |
| 01/07/2004 | EP1377550A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 01/06/2004 | US6673817 Anticoagulants |
| 01/06/2004 | US6673801 Dihydroxyhexanoic acid derivatives |
| 01/06/2004 | US6673799 Inhibits binding to androgen receptor; antiandrogen |
| 01/06/2004 | US6673795 Pyrimidine, pyrazine and triazane derivatives |
| 01/06/2004 | US6673788 Containing 2,2,2-trifluoro-1-oxoethyl groups |
| 01/06/2004 | US6673784 Halosubstituted acetophenones as selective herpesvirus protease inhibitors |
| 01/06/2004 | US6673257 Blends employing at least two organic compounds having known melt temperatures, exhibit improved thermal properties and performance characteristics |
| 01/02/2004 | EP1373272A2 Tert. alkylphenoxy substituted polycyclic compounds |
| 01/02/2004 | EP1373226A1 Process for the enhancement of cycle life of a zinc-chromium based catalyst in the synthesis of 2-methylpyrazine |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1044187B1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 01/01/2004 | US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound |
| 01/01/2004 | US20040002503 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 01/01/2004 | US20040002123 Detection of transmembrane potentials by optical methods |
| 01/01/2004 | US20040001970 Organic electroluminescent materials and devices made from such materials |
| 12/31/2003 | WO2004000820A2 Certain aromatic monocycles as kinase modulators |
| 12/31/2003 | WO2004000811A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 12/31/2003 | WO2004000809A1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays |
| 12/31/2003 | WO2004000797A1 Alpha-sulfonylamino-acetonitriles |
| 12/31/2003 | WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators |
| 12/31/2003 | WO2004000762A2 Propionic acid derivatives and their use as hppars activators |
| 12/31/2003 | WO2004000318A2 Certain amino-substituted monocycles as kinase modulators |
| 12/31/2003 | CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors |
| 12/31/2003 | CN1132815C 杂芳香族醛类的制造方法 The method of manufacturing the heteroaromatic aldehyde |
| 12/31/2003 | CA2490646A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 12/31/2003 | CA2489359A1 Propionic acid derivatives and their use as hppars activators |
| 12/31/2003 | CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators |
| 12/31/2003 | CA2486958A1 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays |
| 12/30/2003 | US6670473 Inhibitors of nitric oxide synthase (nos) |
| 12/30/2003 | CA2198637C Preparation of quaternized glycine nitriles |
| 12/30/2003 | CA2051399C Therapeutically useful 2-aminotetralin derivatives |
| 12/29/2003 | CA2433983A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 12/25/2003 | US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS |
| 12/25/2003 | US20030236261 Potassium channel inhibitors |
| 12/25/2003 | US20030236259 Novel aryl- and heteroarylpiperazines |
| 12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
| 12/25/2003 | US20030236248 Kappa agonist compounds and pharmaceutical formulations thereof |
| 12/25/2003 | US20030235612 Compounds and compositions for delivering active agents |
| 12/24/2003 | WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 12/24/2003 | WO2003106405A1 Aspartyl protease inhibitors |
| 12/24/2003 | WO2003106381A2 Human adam-10 inhibitors |
| 12/24/2003 | WO2003072558A3 Arylsulfone derivatives |
| 12/24/2003 | WO2003070182A3 Sodium channel blockers |
| 12/24/2003 | CN1463263A Method to inhibit ethylene responses in plants |